Jaboulay strictureplasty vs gastrojejunostomy: morbidity
Does Jaboulay duodenal strictureplasty result in lower postoperative morbidity than gastrojejunostomy for duodenal strictures
What is known
- In the Birmingham series, early complications (fistula, obstruction) and long-term restricture were more frequent after duodenal strictureplasty than gastrojejunostomy; no bypass patient needed reoperation for early complications. 1
- That series concluded strictureplasty has no obvious advantage over gastrojejunostomy for obstructive duodenal Crohn's. 1
- Gastrojejunostomy morbidity was later reoperation for stomal ulceration (2/13) and anastomotic obstruction (4/13); vagotomy was not clearly protective. 1
- One small series reported bypass patients were slow to regain intestinal function (~20%), needing parenteral nutrition and prolonged stays, whereas strictureplasty avoids blind loop, bile reflux, and vagotomy/stomal ulceration. 1,2
What is unknown / caveats
- Birmingham series found strictureplasty had higher early complications than bypass; other single-arm series report strictureplasty as safe with no postoperative complications
- Jaboulay is described as a form of strictureplasty in some texts and as a gastroduodenostomy bypass in others, so the two arms are not cleanly separable
- No head-to-head Jaboulay vs gastrojejunostomy data
- All evidence is small retrospective cohorts of a rare condition, mixing strictureplasty types and bypass configurations
- The specific Jaboulay-versus-gastrojejunostomy comparison the question asks about is not addressed by any retrieved study.
References
- Yamamoto T, Bain IM, Connolly AB, Allan RN, Keighley MR. Outcome of strictureplasty for duodenal Crohn's disease. Br J Surg. 1999;86(2):259-62. PMID: 10100799.
- [No authors listed]. Strictureplasty is an effective option in the operative management of duodenal Crohn's disease. Dis Colon Rectum. 1999;42(5):596-600. PMID: 10344680.
For educational use only, not a substitute for clinical judgement or medical advice. Consult qualified clinicians for diagnosis and treatment decisions. This tool may contain errors; use the flag button below to report inaccurate or harmful content.
Draft, generated by the IBDology RAG and not yet clinician-reviewed. Answers are grounded in the retrieved literature listed above; a high faithfulness score means the answer matches its sources, not that the sources are correct.
answered 2026-08-04 · corpus build b71369a6 · faithfulness 1.0
Reviewer notes